Medical treatment of ulcerative colitis

1969 ◽  
Vol 4 (1) ◽  
pp. 23-24
Author(s):  
Yoshinori Nao ◽  
Hiroshi Obata
Keyword(s):  
Ulcerative Colitis ◽  
Medical Treatment

scholarly journals Medical treatment of ulcerative colitis: scoring the advances.

Gut ◽  
1988 ◽  
Vol 29 (10) ◽  
pp. 1298-1303 ◽  
Author(s):  
C J Hawkey ◽  
A B Hawthorne
Keyword(s):  
Ulcerative Colitis ◽  
Medical Treatment

scholarly journals PATIENTS WITH INFLAMMATORY BOWEL DISEASE PERSPECTIVE ON COVID-19 AND HEALTH CARE SERVICE DURING THE PANDEMIC

2021 ◽  
Vol 27 (Supplement_1) ◽  
pp. S50-S51
Author(s):  
Randi Opheim ◽  
Kristian Moum ◽  
Bjørn Moum
Keyword(s):  
Ulcerative Colitis ◽  
Health Care ◽  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Medical Treatment ◽  
Biological Therapy ◽  
Care Service ◽  
Health Care Service ◽  
Inflammatory Bowel

Abstract Background Patients with inflammatory bowel diseases (IBD) have experienced changes to the routine management of their conditions during the coronavirus disease (COVID-19) pandemic. The disease as well IBD treatment frequently require immunosuppressant medications, which could increase their risk of infection. The aim of this study was to determine patients’ experience of the health care service, including the restrictions of hospitals visits made in Norway from Mars 12th 2020. Method From June 18 to September 18 2020, all patients at the IBD outpatient clinic at Oslo University Hospital in Norway on biological therapy or other immunosuppressant’s were included. A questionnaire including patients concerns regarding their disease, medical therapy and COVID-19, as well as their health care service needs in follow-up during the COVID-19 pandemic. Results Altogether 506 IBD patients answered a paper-based questionnaire. The mean age was 40.78 (SD 14.71), 289/506 (57%) men, ulcerative colitis 199/506 (39%), Crohn’s disease 307/506 (61%). Sixty-three patients (12.5%) used biological therapy in combination with azathioprine or steroids. Ninety-one (18.2%) were in obligated quarantine with negative test. Five patients (4.9%) tested positive to SARS- CoV-2 of the 98 patients tested, (1.0% of the total sample). One third of the IBD patients perceived they had increased risk for being infected by SARS- CoV-2 because of the immunosuppressive drugs they used. Nonetheless, 496/506 (98.6%) of the patients adhered to continuing their medication. One-hundred and sixty-one (32.3%) voluntarily isolated, and 21/506 (4.2%) was in sick leave being afraid of being infected. Furthermore, 20/506 (4.0%) cancelled their consultation because they were afraid of being infected from SARS- CoV-2 at the hospital. The hospital changed physical consultation to telephone consultation for 75/506 (15.0%) of the patients. Thirty-eight patients (7.6%) reported that they were afraid of going to the hospital because of restrictions due to the COVID-19 pandemic, and 18/506 (3.6%) did not feel safe when at hospital. Approximately half of the IBD patients (219/506) were satisfied with the information provided by physician about medical treatment for IBD and Covid-19 while 398/506 (77.3%) were satisfied with the information from health-care providers about restrictions due to COVID-19. There were no statistical differences between Crohn’s disease and ulcerative colitis. Conclusion IBD patients on biological treatment and immunosuppressives took precautions because of fear of being infected with SARS- CoV-2. At the same time, they adhere to medical treatment regimens and follow-up at the hospital. Most patients were satisfied with the information they received from physicians and other health-care workers. One percent tested positive to SARS-CoV-2.

scholarly journals Medical treatment of severe ulcerative colitis

2002 ◽  
Vol 16 ◽  
pp. 7-12 ◽  
Author(s):  
M. Daperno ◽  
R. Sostegni ◽  
R. Rocca ◽  
C. Rigazio ◽  
N. Scaglione ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Medical Treatment ◽  
Severe Ulcerative Colitis

scholarly journals The medical treatment of ulcerative colitis.

1968 ◽  
Vol 44 (515) ◽  
pp. 696-707 ◽  
Author(s):  
G. Watkinson
Keyword(s):  
Ulcerative Colitis ◽  
Medical Treatment

Medical treatment and management of severe ulcerative colitis

2008 ◽  
Vol 40 ◽  
pp. S280-S284
Author(s):  
F. Rizzello ◽  
M. Campieri ◽  
R. Tambasco ◽  
G. Straforini ◽  
R. Brugnera ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Medical Treatment ◽  
Severe Ulcerative Colitis

scholarly journals Disease state and medical treatment of ulcerative colitis.

1993 ◽  
Vol 82 (9) ◽  
pp. 1480-1485
Author(s):  
HITOSHI ASAKURA
Keyword(s):  
Ulcerative Colitis ◽  
Medical Treatment ◽  
Disease State
Sign in / Sign up

Export Citation Format

Share Document